Microdosing psilocybin for fibromyalgia — 4 months of tracking
I have fibromyalgia and tracked 4 months of microdosing with pain diaries, sleep logs, and medication use. Here's what the data shows.
I was diagnosed with fibromyalgia seven years ago. I've tried most of the standard treatments — pregabalin, duloxetine, physical therapy, low-dose naltrexone. All partial at best. I'm a biologist and I track everything obsessively, so when I started microdosing I did it with pain diaries, sleep logs, and daily mood ratings.
Protocol: 0.1–0.15g dried B+ on a Fadiman protocol (dose day, rest, rest, repeat). I weigh on a milligram scale. Four months of data, roughly 40 dose days total.
What the data showed:
- Pain: Mean daily pain rating dropped from 5.2 to 4.1 (10-point scale). Not dramatic, but consistent and meaningful for quality of life. The variance also decreased — fewer 8/9 days.
- Sleep: Sleep quality improved on post-dose days. The third day of each cycle (day before the next dose) often had my worst sleep. Unclear if this is real or tracking artifact.
- Mood and energy: Most consistently positive effect. Emotional reactivity to pain decreased — the suffering component of pain, separate from intensity, seemed reduced.
- Medication use: PRN pain medication use dropped by roughly 30% over the 4 months.
Limitations I'm honest about: This is one person with no control condition. Placebo effect, seasonal variation, regression to the mean — all could explain these results. I have not done a blinded self-experiment. What I can say is that the changes felt qualitatively different from placebo effects I've experienced before, and they were consistent across 4 months rather than fading.
I'm continuing. I'm not stopping my other treatments. And I've started logging more rigorously to look for dose-response patterns.
More Experience Reports
Three years of talk therapy, one psilocybin session, and a fundamentally different relationship with anxiety. A first-timer's account of a licensed Oregon session.
Read →What happens when you underestimate a potent strain. A first-person account of a difficult experience, how the STOP protocol made the difference, and what emerged from the center of it.
Read →A Marine veteran with treatment-resistant PTSD reflects 60 days after participating in a university psilocybin clinical trial. The session didn't cure anything. But the relationship changed.
Read →